Parnate Tablet, Film Coated
Product Images NDC 59212-447

2 FDA label images from Advanz Pharma (us) Corp. · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Parnate (NDC 59212-447). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Advanz Pharma (us) Corp., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structural Formula (Structural Formula)

Structural Formula (Structural Formula)
Chemical structure of tranylcypromine sulfate, showing the molecular arrangement including an amine group, cyclopropyl ring, and phenyl ring with sulfate (H2SO4) elements.*
FDA Label Image

1 (Parnate Label 10mg)

1 (Parnate Label 10mg)
Label for PARNATE 10 mg tablets, containing tranylcypromine sulfate in film-coated oral tablet form. The package contains 100 tablets and is labeled for prescription use only. Manufactured for Advanz Pharma (US) Corp., the label includes storage instructions, dosage details, and a federal law notice about dispensing with the Medication Guide. The product NDC is 59212-447-10.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.